Loading resource…

Centers for Disease Control and Prevention, Office of Infectious Diseases, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination
The guidelines address the complexities of treating patients with both HIV and tuberculosis, emphasizing the importance of managing drug interactions between antiretrovirals and tuberculosis medications. It includes recommendations for various patient populations, including adults, children, and pregnant women. The document also discusses the role of rifamycins in tuberculosis treatment and provides specific recommendations for co-administering antiretroviral drugs with rifampin and rifabutin.
No account needed